Hikma Pharmaceuticals PLC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hikma Pharmaceuticals PLC with three other
companies in this sector in the United Kingdom:
sales of £570.50 million [US$795.68 million]
of which 38%
was Interventional Medicine),
Croda International Plc
(£1.37 billion [US$1.92 billion]
of which 34%
was Personal Care), and
(£839.48 million [US$1.17 billion]
Hikma Pharmaceuticals PLC reported sales of £1.49 billion (US$2.07 billion)
December of 2017.
increase of 2.5%
versus 2016, when the company's sales were £1.45 billion.
Sales at Hikma Pharmaceuticals PLC have increased during each of the previous five years
(and since 2012, sales have increased a total of 114%).